Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of antibiotics in conjunction with oral bone augmentation procedures (BAS20)
2024-517402-28-00Phase 2Authorised
- Sponsor
- Karolinska Institutet
- Start
- Nov 2024
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in surgical site infection (SSI) comparing Perioperative Amimox with Perioperative Kåvepenin (2 arms). Primary endpoint: Occurrence of postoperative infection. Planned start Nov 2024; status: authorised.
02
Drugs
amoxicillinphenoxymethylpenicillin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2024-517402-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517402-28-00.